Agarwal Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 24-10-2024
- Paid Up Capital ₹ 5.00 M
as on 24-10-2024
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.76 Cr
as on 24-10-2024
- Revenue 9.99%
(FY 2023)
- Profit 2.24%
(FY 2023)
- Ebitda -9.85%
(FY 2023)
- Net Worth 23.79%
(FY 2023)
- Total Assets 5.33%
(FY 2023)
About Agarwal Life Sciences
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹4.76 Cr.
Ranju Pilani, Manjudevi Pilani, and Akansha Pilani serve as directors at the Company.
- CIN/LLPIN
U24100MH2010PTC198446
- Company No.
198446
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jan 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Agarwal Life Sciences Private Limited offer?
Agarwal Life Sciences Private Limited offers a wide range of products and services, including Flavours & Aromatics, Food Acidulant, Fertilizers and Soil Additives, Micronutrient Fertilizers, Common Disease Medicines, Anaemia Medicine, Chemical Reagents & Catalysts, Ferrous Compounds, Sulfur Fertilizers.
Who are the key members and board of directors at Agarwal Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ranju Pilani  | Director | 04-Jan-2010 | Current |
| Manjudevi Pilani | Additional Director | 26-Jul-2023 | Current |
| Akansha Pilani | Director | 04-Jan-2010 | Current |
Financial Performance of Agarwal Life Sciences.
Agarwal Life Sciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.99% increase. The company also saw a slight improvement in profitability, with a 2.24% increase in profit. The company's net worth Soared by an impressive increase of 23.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Agarwal Life Sciences?
In 2023, Agarwal Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
United Biochemicals Private LimitedActive 19 years 5 monthsRanju Pilani and Akansha Pilani are mutual person
- Sun Bulkactives Private LimitedActive 17 years 4 months
Ranju Pilani and Akansha Pilani are mutual person
- Millennium Lifecare LimitedActive 25 years 25 days
Ranju Pilani and Manjudevi Pilani are mutual person
- Gi Corporate Advisors Private LimitedActive 29 years 9 months
Ranju Pilani and Manjudevi Pilani are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 May 2012 | ₹4.76 Cr | Open |
How Many Employees Work at Agarwal Life Sciences?
Agarwal Life Sciences has a workforce of 32 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Agarwal Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agarwal Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
